Publication

Article

BioPharm International

BioPharm International-02-01-2012
Volume25
Issue 2

BioPharm International, February 2012 Issue (PDF)

Investing in BioPharma Outsourcing

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue
BioPharm International, February 2012 Issue (PDF)
Trends and Challenges in Biologics Outsourcing: A Q&A with Stephen Taylor
Outsourcing_Web-Figure-1-757935-1408611575680.gif
Biomanufacturing Outsourcing Outlook
93522323-757939-1408611558681.jpg
Preparing For the New China
sb10065413a-001-757929-1408611594025.jpg
What the 2011 Census of India Reveals for Pharma
FRichmond-head-757933-1408611582383.jpg
Saving the Next Generation of Regulatory Scientists

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Related Content
Quality Control Laboratory medicine. Chromatograph operation. A woman makes an analysis on a gas chromatograph. Development of a new vaccine against the covid-19 virus. | Image Credit: © neznamov1984 - © neznamov1984 - stock.adobe.com
August 15th 2025

ElevateBio BaseCamp Achieves First Multi-Modality ICMC Certification in Commercial CGT Manufacturing

Feliza Mirasol
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 15th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Businessman look at higher career barriers ambitious to overcome | Image Credit: © Lerbank-bbk22 - stock.adobe.com
August 15th 2025

Biopharma Development Hurdles: Lessons from Vedanta’s Live Bacteria Cocktail Failure

Christopher Cole
Mastering Antibody-Drug Conjugates
August 15th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Site Logo
August 15th 2025

A Strategic Manufacturing Partner

Emergent
Background with viruses. Adeno-associated virus serotype 1. Virus is used as a vector for gene therapy. A model is built using data of viral macromolecular structure from Protein Data Bank (PDB 3NG9) | Image credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
August 15th 2025

ProBio Launches End-to-End AAV Production at NJ Manufacturing Site

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.